Larson Financial Group’s Immunocore IMCR Stock Holding History

Larson Financial Group’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36K	Sell	43 -20	-32%	-$592	﹤0.01%	3222
2026 Q1	$1.9K	Buy	63 +53	+530%	+$1.72K	﹤0.01%	2969
2025 Q4	$347	Hold	10	–	–	﹤0.01%	3190
2025 Q3	$363	Hold	10	–	–	﹤0.01%	3159
2025 Q2	$314	Hold	10	–	–	﹤0.01%	2964
2025 Q1	$297	Hold	10	–	–	﹤0.01%	2699
2024 Q4	$295	Hold	10	–	–	﹤0.01%	2341
2024 Q3	$311	Hold	10	–	–	﹤0.01%	2247
2024 Q2	$339	Hold	10	–	–	﹤0.01%	1932
2024 Q1	$650	Hold	10	–	–	﹤0.01%	1518
2023 Q4	$683	Sell	10 -3	-23%	-$156	﹤0.01%	1532
2023 Q3	$675	Buy	+13	New	+$769	﹤0.01%	1545

Other funds holding IMCR

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Larson Financial Group's IMCR Position: Q2 2026 in Review

Larson Financial Group reduced its Immunocore (IMCR) stake by 32% in Q2 2026, selling an estimated $592 and leaving 43 shares worth $1.36K. The position accounts for ﹤0.01% of the portfolio, ranked #3222.

Larson Financial Group first reported a position in IMCR in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.9K in Q1 2026. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

Larson Financial Group held 43 shares of Immunocore worth $1.36K as of Q2 2026.
Larson Financial Group sold 20 Immunocore shares in Q2 2026, an estimated $592.
Immunocore made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3222 holding.
Larson Financial Group first reported a position in Immunocore in Q3 2023 and has held it in 12 quarters since.
Larson Financial Group's Immunocore position peaked at $1.9K in Q1 2026.
136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.